powered by
Home | About Us | Projects | Publications | Staff | NY HIV Research Consortium | Contact Us
  Staff

Overview
Affiliated-Investigators and Staff
 
 

Staff Bio

Holly Hagan, Ph.D.

Position Title

  • Core Director, Interdisciplinary Research Methods Core, CDUHR
  • Deputy Director, CDUHR
  • Principal Investigator

Affiliation
New York University College of Nursing

Education
Ph.D., Epidemiology, University of Washington

Research Interests

  • Etiology and prevention of hepatitis C and other blood-borne viral infections in drug users and other populations at risk
  • Access to screening and health care among drug users
  • Epidemiological research methodology

Current Projects

  • Principal Investigator, National HIV Behavioral Surveillance - New York City
  • Principal Investigator, Reducing HIV Transmission by Promoting Sexual Health among Drug Users
  • Co-Investigator, HIV Infection in Ethnic Minority IDUs: An International Systematic Review
  • Co-Investigator, Multiple HIV Prevention Packages for IDUs in Estonia
  • Co-Investigator, Risk Factors for HIV/AIDS in Drug Users

Awards and Memberships

  • Member, Behavioral and Social Consequences of HIV/AIDS Study Section (BSCH), Center for Scientific Review, National Institutes of Health
  • Predoctoral Fellowship, National Institute on Drug Abuse, National Institute of Health, 1995-1997
  • Member, Society for Epidemiologic Research
  • Member, American Public Health Association

Academic Appointments

  • Clinical Assistant Professor, Department of Epidemiology, School of Public Health and Community Medicine, University of Washington

Selected Publications Sort Results By: Author | Title | Year

Burt, R. D., Hagan, H., Sabin, K., & Thiede, H. (2010). Evaluating respondent-driven sampling in a major metropolitan area: Comparing injection drug users in the 2005 Seattle area National HIV Behavioral Surveillance System Survey with participants in the RAVEN and Kiwi studies. Annals of Epidemiology, 20 (2), 159-167.

Coffin, L. S., Newberry, A., Hagan, H., Cleland, C. M., Des Jarlais, D. C., & Perlman, D. C. (2010). Syphilis in drug users in low and middle income countries. International Journal of Drug Policy, 21 (1), 20-27.

Hagan, H., Pouget, E. R., Williams, I. T., Garfein, R. L., Strathdee, S. A., Hudson, S. M., Latka, M. H., & Ouellet, L. J. (2010). Attribution of hepatitis C virus seroconversion risk in young injection drug users in 5 US cities. Journal of Infectious Diseases, 201 (3), 378-385.

Brewer, D. D., & Hagan, H. (2009). Evaluation of a patient referral contact tracing programme for hepatitis B and C virus infection in drug injectors. Eurosurveillance, 14 (14), 5-9.

Burt, R. D., Thiede, H., & Hagan, H. (2009). Serosorting for hepatitis C status in the sharing of injection equipment among Seattle area injection drug users. Drug and Alcohol Dependence, 105 (3), 215-220.

Des Jarlais, D. C., Arasteh, K., Hagan, H., McKnight, C., Perlman, D. C., & Friedman, S. R. (2009). Persistence and change in disparities in HIV infection among injection drug users in New York City after large-scale syringe exchange programs. American Journal of Public Health, 99 (Suppl 2), S445-S451.

Des Jarlais, D. C., Arasteh, K., McKnight, C., Hagan, H., Perlman, D., & Friedman, S. R. (2009). Using hepatitis C virus and herpes simplex virus-2 to track HIV among injecting drug users in New York City. Drug and Alcohol Dependence, 101 (1-2), 88-91.

Jenness, S. M., Murrill, C. S., Liu, K. L., Wendel, T., Begier, E., & Hagan, H. (2009). Missed opportunities for HIV testing among high-risk heterosexuals. Sexually Transmitted Diseases, 36 (11), 704-710.

Lelutiu-Weinberger, C., Pouget, E. R., Des Jarlais, D., Cooper, H. L., Scheinmann, R., Stern, R., Strauss, S. M., & Hagan, H. (2009). A meta-analysis of the hepatitis C virus distribution in diverse racial/ethnic drug injector groups. Social Science and Medicine, 68 (3), 579-590.

Rondinelli, A. J., Ouellet, L. J., Strathdee, S. A., Latka, M. H., Hudson, S. M., Hagan, H., & Garfein, R. S. (2009). Young adult injection drug users in the United States continue to practice HIV risk behaviors. Drug and Alcohol Dependence, 104 (1-2), 167-174.

Brewer, D. D., Hagan, H., & Hough, E. S. (2008). Improved injection network ascertainment with supplementary elicitation techniques. International Journal of STD and AIDS, 19 (3), 188-191.

Des Jarlais, D. C., Arasteh, K., & Hagan, H. (2008). Evaluating Vancouver's supervised injection facility: Data and dollars, symbols and ethics. Canadian Medical Association Journal, 179 (11), 1105-1106.

Friedman, S. R., Mateu-Gelabert, P., Sandoval, M., Hagan, H., & Des Jarlais, D. C. (2008). Positive deviance control-case life history: A method to develop grounded hypotheses about successful long-term avoidance of infection. BMC Public Health, 8 (1), 94.

Hagan, H., Pouget, E. R., Des Jarlais, D. C., & Lelutiu-Weinberger, C. (2008). Meta-regression of hepatitis C virus infection in relation to time since onset of illicit drug injection: The influence of time and place. American Journal of Epidemiology, 168 (10), 1099-1109.

Latka, M. H., Hagan, H., Kapadia, F., Golub, E. T., Bonner, S., Campbell, J. V., Coady, M. H., Garfein, R. S., Pu, M., Thomas, D. L., Thiel, T. K., & Strathdee, S. A. (2008). A randomized intervention trial to reduce the lending of used injection equipment among injection drug users infected with hepatitis C. American Journal of Public Health, 98 (5), 853-861.

Munoz-Plaza, C. E., Strauss, S., Astone-Twerell, J., Des Jarlais, D., Gwadz, M., Hagan, H., Osborne, A., & Rosenblum, A. (2008). Exploring drug users' attitudes and decisions regarding hepatitis C (HCV) treatment in the U.S.. International Journal of Drug Policy, 19 (1), 71-78.

Stern, R. K., Hagan, H., Lelutiu-Weinberger, C., Des Jarlais, D., Scheinmann, R., Strauss, S., Pouget, E. R., & Flom, P. (2008). The HCV Synthesis Project: Scope, methodology, and preliminary results. BMC Medical Research Methodology, 8:62.

Strauss, S. M., Munoz-Plaza, C., Tiburcio, N. J., Astone-Twerell, J., Des Jarlais, D. C., Gwadz, M., Hagan, H., Osborne, A., & Rosenblum, A. (2008). Barriers and facilitators to undergoing hepatitis C virus (HCV) testing through drug treatment programs. Journal of Drug Issues, 38 (4), 1161-1185.

Bailey, S. L., Ouellet, L. J., Mackesy-Amiti, M. E., Golub, E. T., Hagan, H., Hudson, S. M., Latka, M. H., Gao, W., & Garfein, R. S. (2007). Perceived risk, peer influences, and injection partner type predict receptive syringe sharing among young adult injection drug users in five U.S. cities. Drug and Alcohol Dependence, 91 (Supplement 1), S18-S29.

Burt, R. D., Hagan, H., Garfein, R. S., Sabin, K., Weinbaum, C., & Thiede, H. (2007). Trends in hepatitis B virus, hepatitis C virus, and human immunodeficiency virus prevalence, risk behaviors, and preventive measures among Seattle injection drug users aged 18-30 years, 1994-2004. Journal of Urban Health, 84 (3), 436-454.

Campbell, J. V., Garfein, R. S., Thiede, H., Hagan, H., Ouellet, L. J., Golub, E. T., Hudson, S. M., Ompad, D. C., & Weinbaum, C. (2007). Convenience is the key to hepatitis A and B vaccination uptake among young adult injection drug users. Drug and Alcohol Dependence, 91 (Supplement 1), S64-S72.

Des Jarlais, D. C., Arasteh, K., Perlis, T., Hagan, H., Abdul-Quader, A., Heckathorn, D. D., McKnight, C., Bramson, H., Nemeth, C., Torian, L. V., & Friedman, S. R. (2007). Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City. AIDS, 21 (2), 231-235.

Des Jarlais, D. C., Arasteh, K., Perlis, T., Hagan, H., Heckathorn, D. D., McKnight, C., Bramson, H., & Friedman, S. R. (2007). The transition from injection to non-injection drug use: Long-term outcomes among heroin and cocaine users in New York City. Addiction, 102 (5), 778-785.

Des Jarlais, D. C., Hagan, H., Arasteh, K., McKnight, C., Perlman, D., & Friedman, S. R. (2007). Herpes simplex virus-2 and HIV among noninjecting drug users in New York City. Sexually Transmitted Diseases, 34 (11), 923-927.

Garfein, R. S., Golub, E. T., Greenberg, A. E., Hagan, H., Hanson, D. L., Hudson, S. M., Kapadia, F., Latka, M. H., Ouellet, L. J., Purcell, D. W., Strathdee, S. A., & Thiede, H. (2007). A peer-education intervention to reduce injection risk behaviors for HIV and hepatitis C virus infection in young injection drug users. AIDS, 21 (14), 1923-1932.
Page(s)
1 2 3 4 5

 
 
© 2010 Center for Drug Use and HIV Research

Home • About Us • Projects • Publications • Staff • NY HIV Research Consortium • Contact Us